Credit Suisse initiates coverage on Specialty Pharmaceuticals: Credit Suisse initiates an Outperform rating on Allergan (NYSE: AGN) - Price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE